The MIC and MBC activity of meziocillin alone and in combination with two concentrations of ceftizoxime, moxalactam, and amikacin and a single concentration of cefoxitin was studied in a broth microdilution partial checkerboard against 472 tested, 38% were resistant to gentamicin. Of the P. aeruginosa strains tested, 38% were resistant to gentamicin (MIC, >4 ,ug/ml), 22% were resistant to amikacin (MIC, >16 ig/ ml), and 9% were resistant to tobramycin (MIC, >4 ,ug/ml). A total of 6% of P. aeruginosa strains were resistant to all three aminoglycosides. All isolates were kept on glass beads in Trypticase soy broth (BBL Microbiology Systems, Cockeysville, Md.) plus 10% glycerol at -80°C until used (3).
The MIC and MBC activity of meziocillin alone and in combination with two concentrations of ceftizoxime, moxalactam, and amikacin and a single concentration of cefoxitin was studied in a broth microdilution partial checkerboard against 472 strains of aerobic gram-negative and gram-positive bacteria. Aziocillin was tested alone and in the same combinations against Pseudomonas aeruginosa. Of the gram-negative bacilli tested, 38% were gentamicin resistant. Antagonism (less than or equal to a fourfold ureidopenicillin MIC increase) was observed frequently with combinations of ureidopenicillins plus cefoxitin and sporadically with ureidopenicillins plus ceftizoxime or moxalactam. Partial synergism (less than or equal to a fourfold ureidopenicillin MIC decrease) was evident with both combinations of ureidopenicillins plus amikacin and ureidopenicillins plus ceftizoxime or moxalactam, the percentage being dependent upon the individual species and combinations.
Combination antibiotic therapy has been used to broaden the antibacterial spectrum in the treatment of unidentified pathogens and possibly prevent or delay the development of resistant orgahisms (13, 20) . Combinations of beta-lactam and aminoglycoside antibiotics have been advocated, but due to the potential oto-and renal toxicity of aminoglycosides and the expanded antibacterial spectrum of new cephalosporins and penicillins, combinations of two beta-lactam antibiotics have been proposed arid used. The potential advantages of such combinations in addition to possible reduced renal toxicity include the following: (i) enhanced antipseudomonas and enterococcal activity by the addition of the penicillin to the cephalosporin, (ii) enhanced staphylococcal and Enterobacteriaceae activity by the addition of the cephalosporin to the penicillin, and (iii) possible synergistic activity against a wide range of potential pathogens. A tested, 38% were resistant to gentamicin. Of the P. aeruginosa strains tested, 38% were resistant to gentamicin (MIC, >4 ,ug/ml), 22% were resistant to amikacin (MIC, >16 ig/ ml), and 9% were resistant to tobramycin (MIC, >4 ,ug/ml). A total of 6% of P. aeruginosa strains were resistant to all three aminoglycosides. All isolates were kept on glass beads in Trypticase soy broth (BBL Microbiology Systems, Cockeysville, Md.) plus 10% glycerol at -80°C until used (3) .
Antibiotic susceptibility tests and synergy studies. Antibiotics were prepared in divalent cation-supplemented MuellerHinton broth (Difco Laboratories, Detroit, Mich.) (1, 19) . Calcium content (.50 ,ug/ml) was confirmed on an ASTRA-8 (Beckman Instruments, Inc., Brea, Calif.) (17) , and the magnesium concentration (-25 ,g/ml) was determined on an atomic absorption spectrophotometer (Instrumentation Laboratories, Inc. [model 253], Lexington, Mass.) (6) . Broth microdilution synergy trays were prepared as partial checkerboards in plastic microdilution panels (Dynatech Laboratories, Inc., Alexandria, Va.) as follows: azlocillin or mezlocillin in serial twofold dilutions from 128 to 0.125 ,ug/ml was tested alone plus combined with two concentrations of ceftizoxime (1 and 64 ,ug/ml), moxalactam (1 and 64 ,ug/ml), and amikacin (2 and 16 ,g/ml) and a single concentration of cefoxitin (8 ,ug/ml). Prepared panels were stored at -80°C.
The MICs of each agent against E. coli 25922, S. aureus 29213, and S. faecalis 29212 control strains (American Type Culture Collection, Rockville, Md.) were determined on the mezlocillin checkerboard, and P. aeruginosa 27853 was tested on both the azlocillin and mezlocillin checkerboards before and after the study commenced.
Panels containing mezlocillin were tested against all isolates, whereas those containing azlocillin were only tested against P. aeruginosa. Each isolate was inoculated into the panels at a final organism density of 5 x 105 to 1 x 106 CFU/ ml, incubated overnight (18 to 20 h) at 35°C, and read as MICs. MBC determination. The entire volume of the first three clear wells (0.1 ml) from each antibiotic combination and mezlocillin or azlocillin alone was subcultured as a single line onto separate 5% sheep blood agar plates. The subculture was allowed to dry onto the agar surface, then streaked in three directions, and incubated at 35°C overnight; the number of CFU was recorded (16) . The MBC was defined as the lowest antibiotic concentration (along with subsequent higher concentrations) at which 0.1% or less of the original inoculum survived after 18 to 20 h of incubation.
Combination interpretation. Antibiotic combination activity was interpreted as follows: partial synergism, a fourfold or greater decrease in the azlocillin or mezlocillin MIC; antagonism, a fourfold or greater increase in the azlocillin or mezlocillin MIC; indifference, the range of changes between synergism and antagonism; no interpretation, this determination was made (i) when any organism was susceptible to a concentration less than or equal to the concentration of the combination antibiotic or (ii) when any organism was resistant to the combination antibiotic concentration and at least a fourfold lowering in the ureidopenicillin MIC or MBC was not observed. RESULTS The azlocillin and mezlocillin concentrations at which 90% of strains were inhibited (MIC90) and killed (MBC9(t) are shown in Table 1 . Ureidopenicillin activity in combination with ceftizoxime, moxalactam, and amikacin is shown in Table 2 (P. aerluginosa, Enterobacteriaceae, S. aureus, and S. faecalis). Data is expressed by percent partial synergism, indifference, and antagonism of the MIC for each combination and also by ureidopenicillin MIC90 and MBC90 alone compared with the combination values. Combinations with less than 10 evaluable isolates were not included in the tables.
Partial MIC synergism occurred with both ureidopenicillin-plus-amikacin and ureidopenicillin-plus-cephalosporin combinations, although percentages varied, depending upon the individual species and combination. Ten isolates of A. calcoaceticus var. anitratus produced 100% indifference with mezlocillin plus 1 pg of moxalactam per ml in data not shown in the tables. Among the Enterobacteriaceae (except S. marcescens), nearly all strains were inhibited by .1 ,ug of ceftizoxime and moxalactam per ml; thus, the few remaining strains were grouped together. The Serratia species consisted of a larger, more resistant species and was analyzed separately. In data not shown in the tables, the percent partial synergistic activity as measured by the MBC was approximately the same or was slightly lower compared with the MIC for both combinations of ureidopenicillins plus amikacin and ureidopenicillins plus cephalosporins.
We observed antagonism most often with the ureidopenicillin-and-cefoxitin combinations when tested against gramnegative bacilli, thus corroborating the method with published reports (8, 11, 15) . Against P. aeruginosa, antagonism occurred with azlocillin plus cefoxitin (38%) and with mezlocillin plus cefoxitin (7%). Another 7% of azlocillin-and 21% of mezlocillin-plus-cefoxitin combinations were not interpretable for antagonism because of the test panel MIC range. Mezlocillin plus cefoxitin also produced antagonism when used against S. marcescens (16%) and E. aerogenes (6%). Another 60% of S. marcescens and 6% of E. aerogenes could not be interpreted for antagonism because of the test panel MIC range. No antagonism was found among grampositive cocci. Sporadic antagonism was observed among a few isolated strains with ureidopenicillins combined with ceftizoxime or moxalactam as listed in Table 2 . DISCUSSION The activity spectrum of azlocillin and mezlocillin is well known (2, 4, 14, 18) . Ureidopenicillins may have enhanced activity when combined with other antibiotics producing synergistic effects (5, 10, 11, 21) . Several methods are used to study antibiotic combinations in vitro and include killing curves, agar or broth dilution checkerboard susceptibility, and isobolograms. The methods differ by effects measured (bacterial killing rate, MIC, or MBC) and may not correlate with each other (12) . We devised a partial broth microdilution checkerboard consisting of serial twofold ureidopenicillin dilutions and two constant (low and high) concentrations of combination antibiotics allowing many organisms and combinations to be analyzed, for partial synergism, indifference, or antagonism with MIC and MBC determinations.
We found significant antagonism among gram-negative bacilli with ureidopenicillins combined with cefoxitin with this method as expected (8, 11, 15 The partial checkerboard method allows for studies of several organisms and many different antimicrobial combinations. Combination interactions can be evaluated from this abridged checkerboard version, and results concur with published data from the complete checkerboard method. Selected organisms from the abridged method could be further studied with the full two-antimicrobial checkerboard technique. The significance of the interactions should be further evaluated in animal and human studies to determine whether the ureidopenicillin-plus cephalosporin combination is as effective as the ureidopenicillin-plus-amikacin regimen.
